{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T07:08:02Z","timestamp":1762844882664,"version":"build-2065373602"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Netw Model Anal Health Inform Bioinforma"],"DOI":"10.1007\/s13721-025-00640-z","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T06:12:28Z","timestamp":1762841548000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative transcriptomic analysis of non-small cell lung cancer: Microenvironment, circulation, and metastasis"],"prefix":"10.1007","volume":"14","author":[{"given":"Adnan","family":"Khosravi","sequence":"first","affiliation":[]},{"given":"Sharareh","family":"Seifi","sequence":"additional","affiliation":[]},{"given":"Babak","family":"Salimi","sequence":"additional","affiliation":[]},{"given":"Maryam","family":"Mabani","sequence":"additional","affiliation":[]},{"given":"Parsa","family":"Rostami","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0198-1255","authenticated-orcid":false,"given":"Masoumeh","family":"Nomani","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"issue":"3","key":"640_CR1","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10549-022-06801-2","volume":"198","author":"AI Aljohani","year":"2023","unstructured":"Aljohani AI, Toss MS, Green AR, Rakha EA (2023) The clinical significance of Cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion development. Breast Cancer Res Treat 198(3):423\u2013435","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"640_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.4103\/bbrj.bbrj_25_20","volume":"4","author":"M Amini","year":"2020","unstructured":"Amini M, Ghanavi J, Farnia P, Karimi M, Ghomi H (2020) In vitro antiproliferative activity of cold atmospheric plasma on small-cell lung carcinoma. Biomedical and Biotechnology Research Journal (BBRJ) 4(1):76\u201380","journal-title":"Biomedical and Biotechnology Research Journal (BBRJ)"},{"issue":"4","key":"640_CR3","doi-asserted-by":"publisher","first-page":"556","DOI":"10.4103\/bbrj.bbrj_311_22","volume":"6","author":"F Arslan","year":"2022","unstructured":"Arslan F, Yal\u00e7in S, Karahan I (2022) The prediction of lung cancer prognosis with blood lipid levels and ratios at the time of diagnosis. Biomedical and Biotechnology Research Journal (BBRJ) 6(4):556\u2013562","journal-title":"Biomedical and Biotechnology Research Journal (BBRJ)"},{"key":"640_CR4","doi-asserted-by":"publisher","first-page":"8054","DOI":"10.3390\/curroncol31120594","volume":"31","author":"F Borella","year":"2024","unstructured":"Borella F, Fucina S, Seminara Y, Denti P, Ferraioli D, Bertero L, Gallio N, Cusato J, Valabrega G, Revelli A et al (2024) Targeting TOP2A in ovarian cancer: biological and clinical implications. Curr Oncol 31:8054\u20138074","journal-title":"Curr Oncol"},{"issue":"2","key":"640_CR5","doi-asserted-by":"publisher","first-page":"983","DOI":"10.21037\/tcr.2019.12.46","volume":"9","author":"H Cai","year":"2020","unstructured":"Cai H, Zhu X, Qian F, Shao B, Zhou Y, Zhang Y, Chen Z (2020) High expression of TOP2A gene predicted poor prognosis of hepatocellular carcinoma after radical hepatectomy. Transl Cancer Res 9(2):983\u2013992","journal-title":"Transl Cancer Res"},{"key":"640_CR6","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/2152432","volume":"2023","author":"K Cai","year":"2023","unstructured":"Cai K, Xie Z, Liu Y, Wu J, Song H, Liu W, Wang X, Xiong Y, Gan S, Sun Y (2023) Identification of potential key genes and prognostic biomarkers of lung cancer based on bioinformatics. BioMed Res Int 2023:2152432","journal-title":"BioMed Res Int"},{"key":"640_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1147366","volume":"14","author":"S Cao","year":"2023","unstructured":"Cao S, Xiao S, Zhang J, Li S (2023) Identification of the cell cycle characteristics of non-small cell lung cancer and its relationship with tumor immune microenvironment, cell death pathways, and metabolic reprogramming. Front Endocrinol (Lausanne) 14:1147366","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"640_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4103\/bbrj.bbrj_26_23","volume":"7","author":"A Chauhan","year":"2023","unstructured":"Chauhan A, Kalra S (2023) Erb-b2 receptor tyrosine kinase 2 interaction with growth factor receptor bound protein 7 acts as a molecular switch to activate non-small cell lung cancer: an in silico prediction. Biomedical and Biotechnology Research Journal (BBRJ) 7(1):111\u2013117","journal-title":"Biomedical and Biotechnology Research Journal (BBRJ)"},{"key":"640_CR10","doi-asserted-by":"publisher","unstructured":"Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, Clark NR, Ma\u2019ayan A (2013) Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14:128 https:\/\/doi.org\/10.1186\/1471-2105-14-128","DOI":"10.1186\/1471-2105-14-128"},{"issue":"5","key":"640_CR11","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.17305\/bb.2024.10253","volume":"24","author":"Q Chen","year":"2024","unstructured":"Chen Q, Ouyang L, Liu Q (2024) Cyclin B1: a potential prognostic and immunological biomarker in pan-cancer. Biomol Biomed 24(5):1150\u20131169","journal-title":"Biomol Biomed"},{"issue":"7","key":"640_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/genes15070903","volume":"15","author":"X Cheng","year":"2024","unstructured":"Cheng X (2024) A comprehensive review of HER2 in cancer biology and therapeutics. Genes 15(7):903","journal-title":"Genes"},{"key":"640_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-99541-4","volume":"15","author":"RB Dhiab","year":"2025","unstructured":"Dhiab RB, Loyaux R, Garinet S et al (2025) MET exon 14 skipping mutations in non-small-cell lung cancer a 3 years screening experience. Sci Rep 15:19347","journal-title":"Sci Rep"},{"key":"640_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00251-024-01366-4","volume":"77","author":"L Diab","year":"2025","unstructured":"Diab L, Al Kattar S, Oueini N et al (2025) Syndecan-1: a key player in health and disease. Immunogenetics 77:9","journal-title":"Immunogenetics"},{"key":"640_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01305-3","volume":"20","author":"R Du","year":"2021","unstructured":"Du R, Huang C, Liu K et al (2021) Targeting AURKA in cancer: molecular mechanisms and opportunities for cancer therapy. Mol Cancer 20:15","journal-title":"Mol Cancer"},{"issue":"4","key":"640_CR16","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1158\/2159-8290.CD-18-0825","volume":"9","author":"JC Dudley","year":"2019","unstructured":"Dudley JC, Schroers-Martin J, Lazzareschi DV, Shi WY, Chen SB, Esfahani MS et al (2019) Detection and surveillance of bladder cancer using urine tumor DNA. Cancer Discov 9(4):500\u2013509","journal-title":"Cancer Discov"},{"issue":"7","key":"640_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2024.104438","volume":"201","author":"M El-Tanani","year":"2024","unstructured":"El-Tanani M, Rabbani SA, El-Tanani Y, Matalka II (2024) Metabolic vulnerabilities in cancer: a new therapeutic strategy. Crit Rev Oncol\/Hematol 201(7):104438","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"640_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01482","volume":"9","author":"Z Elgundi","year":"2020","unstructured":"Elgundi Z, Papanicolaou M, Major G, Cox TR, Melrose J, Whitelock JM, Farrugia BL (2020) Cancer metastasis: the role of the extracellular matrix and the Heparan sulfate proteoglycan Perlecan. Front Oncol 9:1482","journal-title":"Front Oncol"},{"issue":"1","key":"640_CR19","doi-asserted-by":"publisher","first-page":"e41457","DOI":"10.1016\/j.heliyon.2024.e41457","volume":"11","author":"E Filipovich","year":"2024","unstructured":"Filipovich E, Gorodkova E, Shcherbakova A, Asaad W, Popov S, Melnichenko G, Mokrysheva N, Utkina M (2024) The role of cell cycle-related genes in the tumorigenesis of adrenal and thyroid neuroendocrine tumors. Heliyon 11(1):e41457","journal-title":"Heliyon"},{"issue":"3","key":"640_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nmeth.1902","volume":"9","author":"N Gehlenborg","year":"2012","unstructured":"Gehlenborg N, Wong B (2012) Points of view: heat maps. Nat Methods 9(3):213","journal-title":"Nat Methods"},{"issue":"4","key":"640_CR21","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.21037\/jtd.2020.04.28","volume":"13","author":"WD Gerull","year":"2021","unstructured":"Gerull WD, Puri V, Kozower BD (2021) The epidemiology and biology of pulmonary metastases. J Thorac Dis 13(4):2585\u20132589","journal-title":"J Thorac Dis"},{"issue":"3","key":"640_CR22","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s10555-020-09898-3","volume":"39","author":"O Gires","year":"2020","unstructured":"Gires O, Pan M, Schinke H, Canis M, Baeuerle PA (2020) Expression and function of epithelial cell adhesion molecule epcam: where are we after 40 years? Cancer Metastasis Rev 39(3):969\u2013987","journal-title":"Cancer Metastasis Rev"},{"key":"640_CR23","doi-asserted-by":"publisher","DOI":"10.1177\/15330338211060202","volume":"20","author":"K Gong","year":"2021","unstructured":"Gong K, Zhou H, Liu H, Xie T, Luo Y, Guo H et al (2021) Identification and integrate analysis of key biomarkers for diagnosis and prognosis of non-small cell lung cancer based on bioinformatics analysis. Technol Cancer Res Treat 20:15330338211060202","journal-title":"Technol Cancer Res Treat"},{"key":"640_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/302649","volume":"2015","author":"F Grossi","year":"2015","unstructured":"Grossi F, Dal Bello MG, Salvi S, Puzone R, Pfeffer U, Fontana V, Alama A, Rijavec E, Barletta G, Genova C, Sini C et al (2015) Expression of ribonucleotide reductase subunit-2 and thymidylate synthase correlates with poor prognosis in patients with resected stages I-III non-small cell lung cancer. Dis Markers 2015:302649","journal-title":"Dis Markers"},{"key":"640_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/bs.apcsb.2023.02.001","volume":"135","author":"A Gupta","year":"2023","unstructured":"Gupta A, Dagar G, Chauhan R, Sadida HQ, Almarzooqi SK, Hashem S, Uddin S et al (2023) Cyclin-dependent kinases in cancer: Role, regulation, and therapeutic targeting. Adv Protein Chem Struct Biol 135:21\u201355","journal-title":"Adv Protein Chem Struct Biol"},{"issue":"4","key":"640_CR26","doi-asserted-by":"publisher","first-page":"877","DOI":"10.21037\/tlcr-22-712","volume":"12","author":"G Hamilton","year":"2023","unstructured":"Hamilton G, Rath B, Stickler S (2023) Significance of circulating tumor cells in lung cancer: a narrative review. Transl Lung Cancer Res 12(4):877\u2013894","journal-title":"Transl Lung Cancer Res"},{"issue":"1","key":"640_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-51681-9","volume":"14","author":"T Han","year":"2024","unstructured":"Han T, Liu Y, Zhou J et al (2024) Development of an invasion score based on metastasis-related pathway activity profiles for identifying invasive molecular subtypes of lung adenocarcinoma. Sci Rep 14(1):1692","journal-title":"Sci Rep"},{"issue":"1","key":"640_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00828-5","volume":"6","author":"Y He","year":"2021","unstructured":"He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, Li B (2021) Targeting PI3K\/Akt signal transduction for cancer therapy. Signal Transduct Target Ther 6(1):425","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"640_CR29","volume":"1876","author":"LJ Hern\u00e1ndez Borrero","year":"2021","unstructured":"Hern\u00e1ndez Borrero LJ, El-Deiry WS (2021) Tumor suppressor p53: biology, signaling pathways, and therapeutic targeting. Biochimica et Biophysica Acta (BBA) 1876(1):188556","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"640_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102315","volume":"97","author":"SK Jha","year":"2024","unstructured":"Jha SK, De Rubis G, Devkota SR, Zhang Y, Adhikari R, Jha LA, Bhattacharya K et al (2024) Cellular senescence in lung cancer: molecular mechanisms and therapeutic interventions. Ageing Res Rev 97:102315","journal-title":"Ageing Res Rev"},{"issue":"3","key":"640_CR31","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.18632\/aging.202292","volume":"13","author":"CY Jin","year":"2020","unstructured":"Jin CY, Du L, Nuerlan AH, Wang XL, Yang YW, Guo R (2020) High expression of RRM2 as an independent predictive factor of poor prognosis in patients with lung adenocarcinoma. Aging 13(3):3518\u20133535","journal-title":"Aging"},{"key":"640_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00954","volume":"10","author":"EK Kleczko","year":"2019","unstructured":"Kleczko EK, Kwak JW, Schenk EL, Nemenoff RA (2019) Targeting the complement pathway as a therapeutic strategy in lung cancer. Front Immunol 10:954","journal-title":"Front Immunol"},{"issue":"9","key":"640_CR33","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.7150\/jca.41415","volume":"11","author":"F Kou","year":"2020","unstructured":"Kou F, Sun H, Wu L, Li B, Zhang B, Wang X, Yang L (2020) TOP2A promotes lung adenocarcinoma cells\u2019 malignant progression and predicts poor prognosis in lung adenocarcinoma. J Cancer 11(9):2496\u20132508","journal-title":"J Cancer"},{"issue":"7","key":"640_CR34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0306450","volume":"31","author":"K Kouhmareh","year":"2024","unstructured":"Kouhmareh K, Martin E, Finlay D, Bhadada A, Hernandez-Vargas H, Downey F, Allen JK, Teriete P (2024) Capture of circulating metastatic cancer cell clusters from lung cancer patients can reveal unique genomic profiles and potential anti-metastatic molecular targets: a proof-of-concept study. PLoS ONE 31(7):19","journal-title":"PLoS ONE"},{"issue":"W1","key":"640_CR35","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, Koplev S et al (2016) Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res 44(W1):W90\u2013W97","journal-title":"Nucleic Acids Res"},{"key":"640_CR36","first-page":"9232","volume":"12","author":"CS Kuo","year":"2018","unstructured":"Kuo CS, Liu CY, Pavlidis S, Lo YL, Wang YW, Chen CH et al (2018) Unique immune gene expression patterns in Bronchoalveolar lavage and tumor adjacent Non-Neoplastic lung tissue in Non-Small cell lung cancer. Front Immunol 12:9232","journal-title":"Front Immunol"},{"issue":"46","key":"640_CR37","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018040","volume":"98","author":"X Li","year":"2019","unstructured":"Li X, Shu K, Wang Z, Ding D (2019) Prognostic significance of KIF2A and KIF20A expression in human cancer: a systematic review and meta-analysis. Medicine (Baltimore) 98(46):e18040","journal-title":"Medicine (Baltimore)"},{"issue":"32","key":"640_CR38","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000026474","volume":"100","author":"S Li","year":"2021","unstructured":"Li S, Li H, Cao Y, Geng H, Ren F, Li K, Dai C, Li N (2021) Integrated bioinformatics analysis reveals CDK1 and PLK1 as potential therapeutic targets of lung adenocarcinoma. Medicine (Baltimore) 100(32):e26474","journal-title":"Medicine (Baltimore)"},{"key":"640_CR39","doi-asserted-by":"publisher","DOI":"10.1177\/15330338231202881","volume":"22","author":"X Lin","year":"2023","unstructured":"Lin X, Cai Y, Zong C et al (2023) Bronchoalveolar lavage as potential diagnostic specimens to genetic testing in advanced nonsmall cell lung cancer. Technol Cancer Res Treat 22:15330338231202881","journal-title":"Technol Cancer Res Treat"},{"issue":"211","key":"640_CR40","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1186\/s12885-021-08308-3","volume":"26","author":"M Lu","year":"2021","unstructured":"Lu M, Fan X, Liao W, Li Y, Ma L, Yuan M, Gu R, Wei Z, Wang C, Zhang H (2021) Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis. BMC Cancer 26(211):616","journal-title":"BMC Cancer"},{"issue":"8","key":"640_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15082250","volume":"15","author":"E Matsubara","year":"2023","unstructured":"Matsubara E, Yano H, Pan C, Komohara Y, Fujiwara Y, Zhao S, Shinchi Y, Kurotaki D, Suzuki M (2023) The significance of SPP1 in lung cancers and its impact as a marker for protumor tumor-associated macrophages. Cancers (Basel) 15(8):2250","journal-title":"Cancers (Basel)"},{"issue":"5","key":"640_CR42","first-page":"409","volume":"72","author":"KD Miller","year":"2022","unstructured":"Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, Kramer J, Siegel RL (2022) Cancer treatment and survivorship statistics. CA Cancer J Clin 72(5):409\u2013436","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"640_CR43","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s43018-019-0011-0","volume":"1","author":"EJ Moding","year":"2020","unstructured":"Moding EJ, Liu Y, Nabet BY et al (2020) Circulating tumor DNA dynamics predict benefit from consolidation. Immunotherapy in locally advanced non-small cell lung cancer. Nat Cancer 1(2):176\u2013183","journal-title":"Nat Cancer"},{"issue":"16","key":"640_CR44","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1158\/0008-5472.CAN-22-0554","volume":"82","author":"VS Nair","year":"2022","unstructured":"Nair VS, Hui AB, Chabon JJ, Esfahani MS, Stehr H, Nabet BY, Zhou L, Chaudhuri AA, Benson J, Ayers K et al (2022) Genomic profiling of bronchoalveolar lavage fluid in lung cancer. Cancer Res 82(16):2838\u20132847","journal-title":"Cancer Res"},{"issue":"1","key":"640_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-024-00651-4","volume":"12","author":"K Nikhil","year":"2024","unstructured":"Nikhil K, Shah K (2024) The significant others of Aurora kinase A in cancer: combination is the key. Biomarker Res 12(1):109","journal-title":"Biomarker Res"},{"issue":"24","key":"640_CR47","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000038508","volume":"103","author":"L Pan","year":"2024","unstructured":"Pan L, Li J, Xu Q, Gao Z, Yang M, Wu X, Li X (2024) HER2\/PI3K\/AKT pathway in HER2-positive breast cancer: a review. Medicine (Baltimore) 103(24):e38508","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"640_CR48","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.ajpath.2017.12.009","volume":"188","author":"T Parimon","year":"2018","unstructured":"Parimon T, Brauer R, Schlesinger SY, Xie T, Jiang D, Ge L, Huang Y, Birkland TP et al (2018) Syndecan-1 controls lung tumorigenesis by regulating miRNAs packaged in exosomes. Am J Pathol 188(4):1094\u20131103","journal-title":"Am J Pathol"},{"issue":"11","key":"640_CR49","doi-asserted-by":"publisher","first-page":"S664","DOI":"10.1016\/j.jtho.2023.09.1275","volume":"18","author":"BM Pfeiffer","year":"2023","unstructured":"Pfeiffer BM, Postma MJ, Hatswell A, Vioix H, Paik PK (2023) EP12.01-59 Tepotinib and Capmatinib in patients with MET exon 14 skipping NSCLC: A matching adjusted indirect comparison (MAIC). J Thorac Oncol 18(11):S664\u2013S665","journal-title":"J Thorac Oncol"},{"issue":"2","key":"640_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113687","volume":"43","author":"E Purcell","year":"2024","unstructured":"Purcell E, Niu Z, Owen S, Grzesik M, Radomski A et al (2024) Circulating tumor cells reveal early predictors of disease progression in patients with stage III NSCLC undergoing chemoradiation and immunotherapy. Cell Rep 43(2):113687","journal-title":"Cell Rep"},{"key":"640_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.pscia.2025.100074","volume":"3","author":"Y Qu","year":"2025","unstructured":"Qu Y, Li SH, Luo H, Li J, Wang T, Han X (2025) The crucial role of SPP1 in osteoporosis, osteoarthritis, and cancer. Pharmaceutical Science Advances 3:100074","journal-title":"Pharmaceutical Science Advances"},{"issue":"2","key":"640_CR52","doi-asserted-by":"publisher","first-page":"257","DOI":"10.14740\/wjon1751","volume":"15","author":"V Ramos-Santillan","year":"2024","unstructured":"Ramos-Santillan V, Oshi M, Nelson E, Endo I, Takabe K (2024) High Ki67 gene expression is associated with aggressive phenotype in hepatocellular carcinoma. World J Oncol 15(2):257\u2013267","journal-title":"World J Oncol"},{"key":"640_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s43168-024-00357-z","volume":"19","author":"SB Sa\u011fmen","year":"2025","unstructured":"Sa\u011fmen SB, Do\u011fan C, C\u00f6mert S et al (2025) The importance of Ki-67 proliferation index in small cell lung cancer. Egypt J Bronchol 19:4","journal-title":"Egypt J Bronchol"},{"issue":"12","key":"640_CR54","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1097\/MLR.0000000000000539","volume":"55","author":"N Sathiakumar","year":"2017","unstructured":"Sathiakumar N, Delzell E, Yun H et al (2017) Accuracy of medicare claim-based algorithm to detect breast, prostate, or lung cancer bone metastases. Med Care 55(12):e144\u2013e149","journal-title":"Med Care"},{"issue":"5","key":"640_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/cells10051056","volume":"10","author":"C Schiliro","year":"2021","unstructured":"Schiliro C, Firestein BL (2021) Mechanisms of metabolic reprogramming in cancer cells supporting enhanced growth and proliferation. Cells 10(5):1056","journal-title":"Cells"},{"key":"640_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1361424","volume":"15","author":"A Shabir","year":"2024","unstructured":"Shabir A, Qayoom H, Haq BU, Abo Mansoor A, Abdelrahim A, Ahmad I et al (2024) Exploring HMMR as a therapeutic frontier in breast cancer treatment, its interaction with various cell cycle genes, and targeting its overexpression through specific inhibitors. Front Pharmacol 15:1361424","journal-title":"Front Pharmacol"},{"key":"640_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.712795","volume":"11","author":"J Shi","year":"2021","unstructured":"Shi J, Chen Y, Wang Z, Guo J, Tong C, Tong J, Hu W, Li C, Li X (2021) Comprehensive bioinformatics analysis to identify the gene HMMR associated with lung adenocarcinoma prognosis and its mechanism of action in multiple cancers. Front Oncol 11:712795","journal-title":"Front Oncol"},{"key":"640_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.02.005","volume":"35","author":"A Siddiqui","year":"2020","unstructured":"Siddiqui A, Ceppi P (2020) A non-proliferative role of pyrimidine metabolism in cancer. Mol Metab 35:100962","journal-title":"Mol Metab"},{"key":"640_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.993820","volume":"10","author":"D Sun","year":"2022","unstructured":"Sun D, Zhang H, Zhang C, Wang L (2022) An evaluation of KIF20A as a prognostic factor and therapeutic target for lung adenocarcinoma using integrated bioinformatics analysis. Front Bioeng Biotechnol 10:993820","journal-title":"Front Bioeng Biotechnol"},{"issue":"3","key":"640_CR60","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"D1","key":"640_CR61","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J et al (2019) STRING v11: protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 47(D1):D607\u2013D613","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"640_CR62","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z (2017) GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res 45(W1):W98\u2013W102","journal-title":"Nucleic Acids Res"},{"key":"640_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.646390","volume":"9","author":"H Tang","year":"2021","unstructured":"Tang H, Chen J, Han X, Feng Y, Wang F (2021) Upregulation of SPP1 is a marker for poor lung cancer prognosis and contributes to cancer progression and cisplatin resistance. Front Cell Dev Biol 9:646390","journal-title":"Front Cell Dev Biol"},{"issue":"14","key":"640_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14143380","volume":"14","author":"JT Thiel","year":"2022","unstructured":"Thiel JT, Daigeler A, Kolbenschlag J, Rachunek K, Hoffmann S (2022) The role of CDK pathway dysregulation and its therapeutic potential in soft tissue sarcoma. Cancers (Basel) 14(14):3380","journal-title":"Cancers (Basel)"},{"issue":"17","key":"640_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14174155","volume":"14","author":"NF Uy","year":"2022","unstructured":"Uy NF, Merkhofer CM, Baik CS (2022) HER2 in non-small cell lung cancer: a review of emerging therapies. Cancers (Basel) 14(17):4155","journal-title":"Cancers (Basel)"},{"issue":"4","key":"640_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/antib13040088","volume":"13","author":"K Wang","year":"2024","unstructured":"Wang K, Hsu R (2024) Anti-MET antibody therapies in non-small-cell lung cancer: current progress and future directions. Antibodies (Basel) 13(4):88","journal-title":"Antibodies (Basel)"},{"issue":"433","key":"640_CR67","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aap8793","volume":"10","author":"Y Wang","year":"2018","unstructured":"Wang Y, Li L, Douville C, Cohen JD, Yen TT, Kinde I et al (2018) Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers. Sci Transl Med 10(433):eaap8793","journal-title":"Sci Transl Med"},{"key":"640_CR68","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-022-01777-x","volume":"39","author":"F Wang","year":"2022","unstructured":"Wang F, Zhang H, Wang H et al (2022) Combination of AURKA inhibitor and HSP90 inhibitor to treat breast cancer with AURKA overexpression and TP53 mutations. Med Oncol 39:180","journal-title":"Med Oncol"},{"key":"640_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-023-00407-7","volume":"7","author":"Q Wang","year":"2023","unstructured":"Wang Q, Bode AM, Zhang T (2023) Targeting CDK1 in cancer: mechanisms and implications. NPJ Precis Oncol 7:58","journal-title":"NPJ Precis Oncol"},{"issue":"5","key":"640_CR70","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1158\/1078-0432.CCR-08-2188","volume":"15","author":"M Wrage","year":"2009","unstructured":"Wrage M, Ruosaari S, Eijk PP, Kaifi JT, Hollm\u00e9n J, Yekebas EF, Izbicki JR et al (2009) Genomic profiles associated with early micrometastasis in lung cancer: relevance of 4q deletion. Clin Cancer Res 15(5):1566\u20131574","journal-title":"Clin Cancer Res"},{"key":"640_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-025-02033-1","volume":"23","author":"Y Xia","year":"2025","unstructured":"Xia Y, Huang C, Zhong M et al (2025) Targeting HGF\/c-MET signaling to regulate the tumor microenvironment: implications for counteracting tumor immune evasion. Cell Commun Signal 23:46","journal-title":"Cell Commun Signal"},{"issue":"3","key":"640_CR72","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.90","volume":"1","author":"Z Xie","year":"2021","unstructured":"Xie Z, Bailey A, Kuleshov MV, Clarke DJB, Evangelista JE, Jenkins SL, Lachmann A et al (2021) Gene set knowledge discovery with enrichr. Current Protocols 1(3):e90","journal-title":"Current Protocols"},{"issue":"5","key":"640_CR73","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abd9738","volume":"7","author":"X Xing","year":"2021","unstructured":"Xing X, Yang F, Huang Q, Guo H, Li J, Qiu M, Bai F, Wang J (2021) Decoding the multicellular ecosystem of lung adenocarcinoma manifested as pulmonary subsolid nodules by single-cell RNA sequencing. Sci Adv 7(5):eabd9738","journal-title":"Sci Adv"},{"issue":"12","key":"640_CR74","doi-asserted-by":"publisher","first-page":"648","DOI":"10.5483\/BMBRep.2018.51.12.205","volume":"51","author":"L Xu","year":"2018","unstructured":"Xu L, Lu C, Huang Y, Zhou J, Wang X, Liu C, Chen J, Le H (2018) SPINK1 promotes cell growth and metastasis of lung adenocarcinoma and acts as a novel prognostic biomarker. BMB Rep 51(12):648\u2013653","journal-title":"BMB Rep"},{"key":"640_CR75","doi-asserted-by":"publisher","DOI":"10.3892\/or.2025.8969","volume":"54","author":"W Xu","year":"2025","unstructured":"Xu W, Bi Z, Lu L, Feng F, Chen L, Zhang C (2025) Role of osteopontin in cancer: from pathogenesis to therapeutics (Review). Oncol Rep 54:136","journal-title":"Oncol Rep"},{"issue":"2","key":"640_CR76","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2023.13918","volume":"26","author":"H Yang","year":"2023","unstructured":"Yang H, He F, Yuan T, Xu W, Cao Z (2023) Clinical features and treatment of bone marrow metastasis. Oncol Lett 26(2):332","journal-title":"Oncol Lett"},{"issue":"2","key":"640_CR77","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.18632\/oncotarget.13653","volume":"8","author":"C Ye","year":"2017","unstructured":"Ye C, Wang J, Wu P, Li X, Chai Y (2017) Prognostic role of Cyclin B1 in solid tumors: a meta-analysis. Oncotarget 8(2):2224\u20132232","journal-title":"Oncotarget"},{"key":"640_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00271","volume":"11","author":"Y You","year":"2020","unstructured":"You Y, He Q, Lu H, Zhou X, Chen L, Liu H, Lu Z, Liu D, Liu Y et al (2020) Silibinin induces G2\/M cell cycle arrest by activating Drp1-dependent mitochondrial fission in cervical cancer. Front Pharmacol 11:271","journal-title":"Front Pharmacol"},{"key":"640_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.860313","volume":"12","author":"X Yu","year":"2022","unstructured":"Yu X, Ji X, Su C (2022) HER2-altered non-small cell lung cancer: biology, clinicopathologic features, and emerging therapies. Front Oncol 12:860313","journal-title":"Front Oncol"},{"issue":"4","key":"640_CR80","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.7150\/jca.51179","volume":"12","author":"X Yuan","year":"2021","unstructured":"Yuan X, Yi M, Dong B, Chu Q, Wu K (2021) Prognostic significance of KRT19 in lung squamous cancer. J Cancer 12(4):1240\u20131248","journal-title":"J Cancer"},{"issue":"5","key":"640_CR81","first-page":"1913","volume":"11","author":"M Zhang","year":"2021","unstructured":"Zhang M, Zhang L, Hei R, Li X, Cai H, Wu X, Zheng Q, Cai C (2021) CDK inhibitors in cancer therapy, an overview of recent development. Am J Cancer Res 11(5):1913\u20131935","journal-title":"Am J Cancer Res"},{"issue":"9","key":"640_CR82","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.1002\/cam4.1710","volume":"7","author":"X Zhao","year":"2018","unstructured":"Zhao X, Zhou LL, Li X, Ni J, Chen P, Ma R, Wu J, Feng J (2018) Overexpression of KIF20A confers malignant phenotype of lung adenocarcinoma by promoting cell proliferation and inhibiting apoptosis. Cancer Med 7(9):4678\u20134689","journal-title":"Cancer Med"},{"issue":"5","key":"640_CR83","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.21037\/jtd-23-539","volume":"15","author":"Q Zhou","year":"2023","unstructured":"Zhou Q, Xu T, Li J, Tan J, Mao Q, Liu T, Wang L, Zhang M (2023) Identification of the potential ferroptosis key genes in lung cancer with bone metastasis. J Thorac Dis 15(5):2708\u20132720","journal-title":"J Thorac Dis"},{"issue":"1","key":"640_CR84","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.gendis.2022.11.022","volume":"11","author":"Z Zuo","year":"2022","unstructured":"Zuo Z, Zhou Z, Chang Y, Liu Y, Shen Y, Li Q, Zhang L (2022) Ribonucleotide reductase M2 (RRM2): regulation, function and targeting strategy in human cancer. Genes Dis 11(1):218\u2013233","journal-title":"Genes Dis"}],"container-title":["Network Modeling Analysis in Health Informatics and Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-025-00640-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13721-025-00640-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-025-00640-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T07:03:29Z","timestamp":1762844609000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13721-025-00640-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["640"],"URL":"https:\/\/doi.org\/10.1007\/s13721-025-00640-z","relation":{},"ISSN":["2192-6670"],"issn-type":[{"type":"electronic","value":"2192-6670"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"20 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors affirm that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"144"}}